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Serum Calcium and 25-Hydroxy 
Vitamin D Level in Normal and Early 
Onset Pre-eclamptic Pregnant 
Women: A Study from Indonesia
INTRODUCTION
Pre-eclampsia is one of the most common causes of maternal and fetal 
morbidity and mortality worldwide. In 2013, the crude incidence was 
2.3% globally, ranging from 1.2-4.0% across regions. In South East 
Asia region, the crude incidence was 2.7% [1]. Compared to developed 
countries, WHO has estimated the incidence of Pre-eclampsia in 
developing countries as seven times higher [2]. In Indonesia, Pre-
eclampsia became the second largest contributor to maternal death 
after haemorrhage in 2013 [3]. In Dr. Soetomo General Hospital, a 
centre for referral hospital in eastern part of Indonesia, Pre-eclampsia 
was responsible for 31% of maternal deaths in 2013-2014 [4].
Pre-eclampsia is a multisystem disorder, defined as hypertension 
developing after 20-weeks gestation and the coexistence of one 
or more of the following new onset conditions: 1) proteinuria; 
2) maternal organ dysfunction; and 3) uteroplacental dysfunction [5]. 
Based on the onset, it is categorised into EOPE and LOPE. EOPE is 
defined as Pre-eclampsia which occurs at <34 weeks gestation age, 
while LOPE is defined as Pre-eclampsia which occurs at ≥34 weeks 
[6]. Although the presenting features overlap, the outcome between 
EOPE and LOPE are different. EOPE is usually accompanied by 
severe complications for both the mother and fetus, while LOPE is 
usually accompanied by relatively mild fetomaternal complication [7]. 
Previous studies which compare the clinical and perinatal outcomes 
between EOPE and LOPE revealed that even though the incidence 
of LOPE are higher than EOPE, the outcomes are worse in EOPE 
in terms of lower gestational age delivery, lower birthweight, lower 
5-minutes APGAR score, higher incidence of stillbirth, early neonatal 
death, and perinatal mortality [6-8]. 
Until now, the pathogenesis of EOPE is not yet fully elucidated. 
Recent theory for the pathogenesis of Pre-eclampsia is two-
staged model, where poorly perfused placenta due to the failure 
in placental vascular remodelling (Stage 1) leads to the clinical 
manifestations of EOPE (Stage 2) [9]. There are several factors 
that have been suggested to be involved in the failure in placental 
vascular remodelling, which are maternal constitutional factors, 
genetic, behavioural, environmental and nutrition intake, modified 
by the physiological changes of pregnancy [9,10]. In contrary, the 
pathogenesis of LOPE is associated with maternal factors. Among 
all maternal factors that may contribute to the LOPE, pre-pregnancy 
Body Mass Index (BMI) seems to play a crucial role [11]. Considering 
that the outcomes are more severe in EOPE than in LOPE, this study 
focused on the factors that contribute to the incidence of EOPE.
Despite the progress in management of Pre-eclampsia, the definitive 
treatment for this multi-system-disorder remains delivery of the 
placenta. Therefore, current studies are focusing on prevention of 
this disorder. It has been known for years that proper nutrition prior 
and throughout pregnancy is important for both mother and fetus. 
In developing countries, where the incidence of Pre-eclampsia is 
higher, pregnant woman consumes diet with lesser amounts of 
essential minerals and vitamins [10]. Independently, calcium and 
vitamin D deficiency has been associated with an increased risk of 
EOPE [12,13].
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ABSTRACT
Introduction: Pre-eclampsia is one of the most common 
causes of fetomaternal morbidity and mortality worldwide. 
This disorder is categorised into Early Onset Pre-eclampsia 
(EOPE) and Late-Onset Pre-eclampsia (LOPE). EOPE is usually 
accompanied by severe complications for both the mother 
and fetus, while LOPE is accompanied by relatively mild 
fetomaternal complications. Although the pathogenesis of 
EOPE is not yet fully elucidated, recent studies indicate that 
serum calcium and 25 Hydroxy Vitamin D (25(OH)D) levels may 
play a role in its pathogenesis.
Aim: To find out the relationship of calcium and 25(OH)D serum 
levels in pregnant women with normal pregnancy and with 
EOPE in Indonesia. 
Materials and Methods: This study was a case-control study, 
conducted in Dr. Soetomo General Hospital from July to October 
2017. A total of 36 women with EOPE and 64 women with 
normal pregnancy were included in this study. Inclusion criteria 
were pregnant women in 2nd or 3rd-trimester with BMI >18 kg/m2. 
Blood sample analysis was done to measure serum calcium 
and 25(OH)D level. Data were expressed as Mean±Standard 
Deviation. Data distribution was analysed using Shappiro-Wilk 
test. Comparison of serum calcium and 25(OH)D level between 
groups was analysed using Independent t-test. Correlation 
between serum calcium and 25(OH)D level was analysed using 
Pearson’s correlation test. The p-value of <0.05 was considered 
significant.
Results: There was a significant difference in serum calcium level 
between case and control group (8.294±0.725 vs 8.670±0.405 
mg/dL; p=0.006). In 25(OH)D level, there was no difference 
between both groups (16.128±7.5463 vs 17.325±6.4992 ng/
mL; p=0.406). No correlation was found between calcium and 
25(OH)D level (r=0.165; p=0.101).
Conclusion: Calcium deficiency plays a role in the incidence of 
EOPE among pregnant women in Indonesia. The actual role of 
calcium deficiency in EOPE needs further investigation.
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the informed consent. Pregnant woman diagnosed with chronic 
hypertension with/without proteinuria, pre-gestational diabetes 
mellitus, gestational diabetes mellitus, acute kidney injury, chronic 
kidney disease, methamphetamine user, and have documented 
autoimmune disease were excluded from this study. 
This study follows the principles of the Declaration of Helsinki. This 
study had received ethical clearance from Dr. Soetomo General 
Hospital before the study began (Ethical Clearance Number 505/
panke.KKE/VIII/2017). All subjects gave their informed consent prior 
to their inclusion in the study. Information for informed consent was 
given before subjects signed the informed consent. Details that might 
disclose the identity of the subjects under study were omitted.
Serum calcium level was presented in mg/dL, while serum 25(OH)D 
level was presented in ng/mL.
STATISTICAl ANAlySIS
Acquired data was analysed using SPSS version 16.0. Data were 
expressed as Mean±Standard Deviation. Data distribution was 
analysed using Shappiro-Wilk test. Comparison of serum calcium 
and 25(OH)D level between two groups was analysed using 
Independent t-test. Correlation between serum calcium and 25(OH)
D level was analysed using Pearson's correlation test. The p-value 
of < 0.05 was considered as statistically significant.
RESUlTS
From June 2017 to October 2017, 36 pregnant women with EOPE 
and 64 pregnant women without EOPE in Dr. Soetomo General 
Hospital were involved in this study. Baseline characteristic showed 
that the maternal ages and BMI between both groups had significant 
differences (p=0.027, p=0.016, respectively). Systolic, diastolic, and 
mean arterial pressure, all showed a statistically significant difference 
between both groups (p=0.0001) [Table/Fig-1].
In this study, mean serum calcium level of pregnant women with 
EOPE pregnancy was 8.294±0.725 mg/dL, while in pregnant 
women with normal pregnancy was 8.670±0.405 mg/dL. There 
was a significant difference between both groups (p=0.006; 95% 
CI=0.1124-0.6393). The mean serum 25(OH)D level of pregnant 
women in EOPE group was 16.128±7.5463 ng/mL, while in control 
group was 17.325±6.4992 ng/mL. No significant difference was 
found between both groups (p=0.406; 95% CI=-0.1659-4.0463) 
[Table/Fig-2]. Pearson’s correlation test showed that there was 
no correlation between serum calcium and serum 25(OH)D level 
(r=0.165; p=0.101).
DISCUSSION
High BMI, old age, and high blood pressure are a risk factor 
for Pre-eclampsia. In the present study, pregnant women with 
EOPE pregnancy had a significantly higher BMI, older age, and 
higher blood pressure compared to pregnant women with normal 
pregnancy. This finding was in accordance with previous study, 
where there was a significant difference in BMI, age, and blood 
pressure between normal pregnancy and preeclamptic pregnancy 
[10]. The odds ratio for pregnant women in low- and middle-
income countries with BMI between 26 and 35 in developing Pre-
eclampsia is 1.71 and rising to 3.90 in pregnant women with BMI 
of >35 kg/m2 [19]. Women aged more than 29-year-old have the 
odd ratio of 1.40 in developing Pre-eclampsia [19]. 
Authors found a lower calcium levels in the EOPE group. This 
finding was consistent with previous studies that show lower 
blood calcium level in pregnant women with Pre-eclampsia. 
Previous study from India shows that the calcium level difference 
is noteworthy (7.84±0.87 mg/dL Vs. 8.97±0.69 mg/dL; p<0.001) 
[10], and another study from Ghana also supports that calcium 
level in pregnant women with Pre-eclampsia was below those 
without Pre-eclampsia (1.168 Vs. 2.368 mmol/L; p<0.0001) [20].
Calcium is needed for fetal cortical bone and trabecular mineralisation 
[14]. In a calcium deficiency situation, there will be maternal bone 
loss to fulfil the requirement. When it is exacerbated by low dietary 
intake, maternal bone turnover will sharply increase to keep up 
with the fetal requirement. Calcium absorption during pregnancy 
is mediated by changes in maternal calciotropic hormones. Low 
calcium intakes during pregnancy may stimulate the secretion of 
PTH, one of the calciotropic hormones, increasing intracellular 
calcium and smooth muscle contractibility, and/or renin release 
from the kidney, leading to vasoconstriction and retention of sodium 
and fluid. These physiological changes lead to the development of 
EOPE [10,14]. On the other hand, vitamin D is mainly crucial for gene 
synthesis in the early development of placenta and the regulation of 
blood calcium and phosphate level [15]. Deficiency of this vitamin 
will induce periphery vascular modulation disturbance and loss 
of renin biosynthesis suppression, which results in inadequate 
placental growth altogether with onset of hypertension, leading to 
EOPE and eclampsia [16]. 
However, there was no study regarding the serum calcium and 
vitamin D level among pregnant woman in Indonesia until the write-
up of the study. The aim of this study were to measure serum levels 
of calcium and 25(OH)D in pregnant woman in Indonesia, in order 
to know whether there was any significant difference in the serum 
levels between pregnant women with normal pregnancy and with 
EOPE pregnancy in Indonesia, and to find out if there was any 
correlation between serum calcium and vitamin D level in pregnant 
women. This study did not include the LOPE pregnancy because 
based on the previous studies, the calcium and vitamin D deficiency 
was related to the incidence of EOPE and not LOPE.
MATERIAlS AND METHODS
The study was a case-control study conducted from June 2017 
to October 2017 in Dr. Soetomo General Hospital, Surabaya, 
Indonesia. Subjects were pregnant women in 2nd and 3rd trimesters. 
History taking, physical examination, and blood sample analysis 
were done to evaluate serum calcium and 25(OH)D level in each 
subject. Blood samples were collected from ante cubital vein using 
a sterile needle and syringe. To obtain the serum, blood samples 
were allowed to clot and then centrifuged at 3000 revolutions per 
minute for 10 minutes. The analysis was done immediately. Serum 
calcium was measured using O-Cresolphthalein-Complexone 
(OCPC) method with MC Reagent Calcium Assay Kit (Japan 
Institute for the Control of Aging (JaICA); Shizuoka; Japan). Calcium 
and OCPC formed a chelate complex with deep red colour, and 
calcium concentration was determined by the absorbance at 
570 nm. Serum 25(OH)D was measured using Chemiluminescent 
Microparticle Immunoassay (CMIA) method with ARCHITECT 25-
OH Vitamin D 5P02 (Abbot Laboratories; Illinois; United States of 
America). In order to measure 25(OH)D concentration using mass 
spectrometry, serum was mixed with anti-vitamin D IgG reagent and 
then washed out several times.
Hundred pregnant women were included in the study, of whom 
36 were pregnant women with EOPE pregnancy as a case 
group and 64 were pregnant women with normal pregnancy 
as control group. EOPE Pregnancy defined as new onset of 
hypertension (≥140 mmHg systolic or ≥90 mmHg diastolic) 
which occurs between 20-34 weeks gestation, with one or more 
of the following new-onset conditions: 1) Proteinuria; 2) maternal 
organs dysfunction; 3) uteroplacental dysfunction [5]. EpiInfoTM 
[17] was used to calculate the sample size, using method 
developed by Kelsey JL et al., [18]. Inclusion criteria for case 
group were pregnant women aged 18-35 with BMI >18 kg/m2, 
fulfilling International Society for the Study of Hypertension in 
Pregnancy (ISSHP) criteria of PE [5], singleton pregnancy, and 
signed the informed consent. Inclusion criteria for control group 
were pregnant women aged 18-35 with BMI >18 kg/m2, did not 
met the ISSHP criteria of PE [5], singleton pregnancy, and signed 
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In this study, no significant difference of 25(OH)D level was found 
between groups. This finding was in accordance with previous 
study which showed that neither vitamin D insufficiency (aOR=1.1; 
95% CI = 0.6-2.0) nor deficiency (aOR = 1.4; 95% CI = 0.7-3.0) was 
significantly associated with Pre-eclampsia [26]. It is because serum 
25(OH)D levels do not change during pregnancy, but an increase in 
1-α hydroxylase and additional synthesis in the placenta allows for 
an increase in the conversion of 25(OH)D to 1,25(OH)2D. Maternal 
serum 1,25(OH)D levels increase 2-folds during pregnancy, allowing 
the intestinal absorption of calcium to double [21]. In contrary, study 
by Bodnar LM et al., revealed that maternal 25(OH)D concentration 
who develop EOPE are significantly lower than control group (45.4 
nmol/L Vs. 53.1 nmol/L, p<0.01) [27]. The difference might be 
because in the present study, mean 25(OH)D level in both pregnant 
women with EOPE pregnancy and normal pregnancy were in the 
deficiency range (16.128±7.5463 ng/mL and 17.325±6.4992 ng/
mL, respectively), whereas the normal range is 32-100 ng/mL [28].
In Southeast Asia, the prevalence of vitamin D deficiency varies 
from 6-70% with cut-off value of 50 nmol/L, whereas in Indonesia 
such specific data is still not available [29]. Pregnant women in this 
category are at risk of suffering bone loss and having neonates 
with hypocalcaemia or rickets [28]. Furthermore, early-pregnancy 
maternal 25(OH)D concentration <15.2 ng/L (37.5 nmol/L) has 5-fold 
increase in the risk of suffering EOPE despite supplementations of 
vitamins [27]. Another study suggests that as vitamin D relies on sun 
exposure, diet, and supplementation, there will only be little or no 
change in vitamin D level during pregnancy [30]. 
In this study, there was no correlation between serum calcium 
and 25(OH)D level. This finding was inconsistent with previous 
study that compare calcium and vitamin D level between calcium 
supplementation with vitamin D supplementation and calcium 
supplementation with 30 minutes of morning sun exposure. It was 
revealed that the level of both calcium and vitamin D was increased 
in group with vitamin D supplementation, but the group with morning 
sun exposure showed decrease level of calcium without any change 
of vitamin D level. [31]. Other study shows remarkable increase of 
25(OH)D level in supplementation of both calcium and vitamin D 
compared to another group with mono-supplementation of calcium, 
despite no elevation of blood calcium level in both groups [32]. Another 
study suggests that serum 1,25(OH)2D would rise in women with low 
calcium intakes (<500 mg/day) and those with adequate intakes in 
late pregnancy, though to a greater or lesser extent depending upon 
intake [14,21]. However, both groups in this study shows low level of 
vitamin D. Authors suggest that due to the low level of both serum 
Calcium and 25(OH)D in this study, there was no feedback mechanism 
that was crucial in calcium metabolism as explained below. 
In normal condition, calcium is maintained between 8.5 mg/dL–10.5 
mg/dL in the blood through the interaction of Parathyroid Hormone 
(PTH), 25(OH)D, and 1,25(OH)2D. In deficiency state, secreted 
PTH will stimulate kidney to convert 25(OH)D into its active form, 
1,25(OH)2D to reabsorbs calcium from the bone, intestines, and 
kidneys [23,33]. Calcium is then transported using either the active 
transport system, which consumes the Adenosine Triphosphate 
(ATP), or passive transport system through diffusion, which depends 
on gradient i.e., through calcium intake. However, in vitamin D 
insufficiency, converted 1,25(OH)2D is inadequate to balance blood 
calcium level, thus diffusion predominates calcium transport system 
[34,35]. Low calcium intake would also aggravate such condition 
since it demands a higher production of 1,25(OH)2D and breakdown 
of its metabolites. Thus, adequate vitamin D status allows calcium 
intake among individuals to become more flexible [35].
lIMITATION
The sample size was low due to the limited funding that the authors 
received. There was a wide variability of the gestational age of 
pregnant women within the inclusion criteria, ranging from 2nd to 
3rd-trimester.





age (Mean±Sd) 30±4.951 27.78±4.638 0.027*
Parity
0 8 (22.2) 21 (32.8)
0.466
1 15 (41.7) 24 (37.5)
2 9 (25) 12 (18.8)
3 2 (5.6) 3 (4.7)
4 1 (2.8) 3 (4.7)
5 1 (2.8) 1 (1.6)
Gravida
1 8 (22.2) 20 (31.2)
0.231
2 10 (27.8) 22 (34.4)
3 12 (33.3) 12 (18.8)
4 2 (5.6) 2 (3.1)
5 2 (5.6) 6 (9.4)
6 0 (0) 1 (1.6)
7 0 (0) 1 (1.6)
8 1 (2.8) 0 (0)
9 1 (2.8) 0 (0)
body Mass Index (kg/m2)
<20 0 (0) 7 (10.9)
0.016*
20-25 12 (33.3) 19 (29.7)
25-30 8 (22.2) 27 (42.2)
30-35 13 (36.1) 7 (10.9)
>35 3 (8.3) 4 (6.2)
Systolic blood pressure 
(mmHg) (Mean±SD)
157.08±19.434 114.38±9.074 0.0001*




<90 mmHg 0 (0) 40 (62.5)
>90 mmHg 36 (100) 24 (37.5)
[Table/Fig-1]: Clinical characteristic.




early onset Pe 
n=36
normal 













[Table/Fig-2]: Serum calcium and 25(OH)D level in normal pregnant woman and 
pregnant woman with early-onset PE.
*p<0.05 was considered statistically significant
During pregnancy, especially in 2nd and 3rd-trimester, calcium 
requirement increases. Previous study reported that woman with a 
daily average calcium intake of 1171 mg during pregnancy absorbs 
57% more during the second trimester and 72% during third trimester 
[21]. However, calcium consumption level of pregnant women 
in Indonesia is only 45-78% below the required estimated dose 
[22]. Although absorption of calcium increases during pregnancy, 
the supplementation of calcium is not necessary as long as daily 
requirement of 1000-1200 mg is fulfilled [14,23]. Hence, calcium 
supplementation in pregnant woman with low calcium intake can 
decrease intracellular calcium concentration, induce vasodilatation 
by decreasing blood vessels smooth muscle contraction, which 
will lead to decrease in blood pressure [24,25]. WHO recommends 
calcium supplementation of 1.5-2 gram of elemental calcium in every 
pregnant woman in low calcium intake area every day [13]. Meta-
analysis studies show that calcium supplementation significantly 
decreases the prevalence of Pre-eclampsia [24,25].
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CONClUSION
Serum calcium level in pregnant women with EOPE pregnancy 
are significantly lower compared to pregnant women with normal 
pregnancy. Serum 25(OH)D level in pregnant women with EOPE 
pregnancy are not significantly lower compare to pregnant women 
with normal pregnancy. There is no correlation between serum calcium 
and 25(OH)D level. It showed that calcium deficiency plays a role in the 
incidence of EOPE among pregnant women in Indonesia. The actual 
role of calcium deficiency in EOPE needs further investigation.
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